An adenovirus based recombinant herpes simplex virus 2 (HSV-2) therapeutic vaccine is highly protective against acute and recurrent HSV-2 disease in a guinea pig model

Name: An adenovirus based recombinant herpes simplex virus 2 (HSV-2) therapeutic vaccine is highly protective against acute and recurrent HSV-2 disease in a guinea pig model
Creator: mingming wan
Published: 2022-09-07T11:06:49.471Z
Keywords: Immunity, Animal Protection

wan, mingming

doi:10.17632/hd962mb4rh.1

An adenovirus based recombinant herpes simplex virus 2 (HSV-2) therapeutic vaccine is highly protective against acute and recurrent HSV-2 disease in a guinea pig model

Published: 7 September 2022| Version 1 | DOI: 10.17632/hd962mb4rh.1

Contributor:

mingming wan

Description

Recombinant adenovirus-based vaccines including rAd-gD2ΔUL25, rAd-ΔUL25, and rAd-gD2 immunized guinea pig model. Humoral and cellular immune responses were described.

Files

Institutions

Jilin University

An adenovirus based recombinant herpes simplex virus 2 (HSV-2) therapeutic vaccine is highly protective against acute and recurrent HSV-2 disease in a guinea pig model

Description

Files

Institutions

Categories

Licence